CLGM
EW icon

Capitolis Liquid Global Markets’s Edwards Lifesciences EW Stock Holding History

Capitolis Liquid Global Markets’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-99,528
Closed -$7.97M – 348
2026
Q1 		$7.97M Buy
99,528
+78,261
+368% +$6.45M 0.05% 203
2025
Q4 		$1.81M Buy
+21,267
New +$1.75M 0.01% 283

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Capitolis Liquid Global Markets's EW Position: Q2 2026 in Review

Capitolis Liquid Global Markets sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 99,528 shares — an estimated $7.97M sold.

Capitolis Liquid Global Markets first reported a position in EW in Q4 2025 and held it in 2 quarters. The position peaked at $7.97M in Q1 2026. 1,332 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Capitolis Liquid Global Markets reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Capitolis Liquid Global Markets sold 99,528 Edwards Lifesciences shares in Q2 2026, an estimated $7.97M.
  • Capitolis Liquid Global Markets first reported a position in Edwards Lifesciences in Q4 2025 and held it in 2 quarters.
  • Capitolis Liquid Global Markets's Edwards Lifesciences position peaked at $7.97M in Q1 2026.
  • 1,332 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.